Bio Protocol
Bio Protocol is designed to make biotechnology more open, efficient and market-driven, from early-stage funding and liquidity, to milestone-based incentives and agentic automation. Users can create a new biotech project and get it bootstrapped by the community, or directly fund and support promising biotech projects at their earliest stages, democratizing an area once limited to Big Pharma and pharma VCs.
Protocol Goals
Selection, creation and acceleration of new projects.
Perpetual funding and liquidity for biotech projects and assets.
Standardization of project frameworks, tokenomics and data/product suites.
Generation and commercialization of scientific IP and data.
Core Operations
To achieve these goals, the Bio Protocol enables 5 core operations:
Selection
Funding
Liquidity
Transparency
Support
1. Selection
BIO token holders participate in selecting which new projects join the ecosystem, enabling a bottom-up approach to funding and developing science.
Projects that are selected by the community can then be funded, added to the treasury and ultimately supported by the Bio Protocol.
As the Bio Protocol relies on high-quality projects, selection requires staking BIO tokens to participate, ensuring that those participating are long-term aligned with the network.
2. Funding
If a project applicant is accepted into the network, all BIO holders with staked tokens qualify to take part in the initial sale of the project.
Through BIO, users are thus able to support groundbreaking science from day one, on equal to or better terms than VCs or other institutions.
For projects, this creates an opportunity to align a pre-established, high-value scientific community (often made up researchers or patients directly affected by the project's scientific mission) to become active stakeholders and participants in R&D, e.g., through decentralized trials and research.
3. Liquidity
Projects should focus on science, not managing liquidity. Bio Protocol alleviates this issue by managing project secondary market liquidity positions.
The protocol supports onchain liquidity using the BIO token and other token holdings in the Bio Protocol treasury.
The BIO token can be paired in liquidity pools with project tokens (e.g., VITA/BIO, HAIR/BIO), as well as with base assets (e.g., BIO/ETH) to facilitate low-cost conversions, accruing fees for the project and the protocol.
4. Transparency
All major protocol decisions are made by the community of token holders, ensuring that the platform evolves in a way that benefits its users, not a central authority.
Projects are held accountable through standardized frameworks passed as governance proposals. Funding can be tied to the successful completion of verifiable milestones, aligning incentives with real-world progress.
Key metrics related to funding, expenditures, and performance are recorded on-chain, providing a clear and immutable record that is accessible to everyone.
5. Support
The protocol provides access to shared tooling and automation, including BioAgents that can perform data analysis, generate hypotheses, and streamline operations, reducing costs and accelerating development for all projects.
Projects can unlock additional
bio/acc
rewards in the form of BIO tokens for hitting critical R&D milestones, creating a powerful incentive to deliver on scientific outcomes.The protocol helps projects maintain momentum through a regular cadence of updates, which are then amplified by a large, engaged community of researchers, investors, and enthusiasts.
Benefits for Researchers
Continuous, Rapid Research Funding – Projects can secure funding quickly through transparent fixed-price sales. High transaction taxes on secondary market trading can then generate a continuous and sustainable revenue stream, directly tying the project's financial health to its ongoing impact and ability to communicate progress effectively.
New Incentive Models & Community Alignment – The protocol introduces new incentive models that reward continuous publication and open-source research, encouraging a culture of transparency and collaboration. Tokens can also be used to align and mobilize patient communities, allowing them to become active participants and stakeholders in the research and development process.
Agentic Science & Automation – Integrated BioAgents and shared tooling automate core scientific tasks, including data analysis, hypothesis testing, and experimental design, while also streamlining project governance and IP management.
Benefits for Backers
Early Access – Staked BIO enables pre-token allocations in vetted projects, offering strategic entry at early-stage valuations.
Community Vetting – Capital deployment is conditional on collective approval, ensuring funds are only allocated to projects with sufficient community support.
Instant Liquidity – Successfully raised funds can automatically injected into onchain liquidity pools, facilitating immediate, low-slippage trading.
Protocol Value Accrual
Holders stake BIO tokens to perform core functions on the network, like vetting new projects or accessing automated services. Protocol fees get recycled back into the ecosystem via liquidity or token burns to fuel growth, while the Bio Protocol Treasury can earn value in the following ways:
Secondary Market Trading Fees: The protocol receives 30% of a 1% fee applied to every secondary market trade of a launched project's token, creating a continuous revenue stream.
Project Token Ownership: The Bio Protocol treasury receives a stake in every project launched through the platform, ensuring it shares in the long-term success of the ecosystem.
Fees from Automated Services: The protocol generates revenue by charging fees for access to shared tooling and specialized services like BioAgents.
Primary Routing & Liquidity Asset: BIO serves as the first and main liquidity pair for project tokens launched on the platform. This means that to trade these assets, users will often need to buy and use BIO, driving demand and transaction volume.
BIO Token
The BIO token can be used for the following purposes:
Staking for Governance & Launch Access: Stake BIO to receive
veBIO
, which provides voting power on protocol upgrades and meta-governance over assets in the treasury. Staked BIO also earnsBioXP
points to participate in project launches.Participating in Launches: Commit BIO to invest in new projects during their initial fixed-price sale.
Providing Liquidity: BIO is the primary pair asset for all project tokens, creating deep liquidity pools on decentralized exchanges.
Accessing Automated Services: Use BIO to pay for services from ecosystem tools like BioAgents.
Ecosystem Discounts: Receive discounts on products and services offered by projects within the Bio Protocol ecosystem.
Last updated